BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25545182)

  • 21. Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia.
    Jansen NC; Kingma A; Schuitema A; Bouma A; Veerman AJ; Kamps WA
    J Clin Oncol; 2008 Jun; 26(18):3025-30. PubMed ID: 18565888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of patients with Down syndrome and acute leukemia: A retrospective observational study.
    Schmidt MP; Colita A; Ivanov AV; Coriu D; Miron IC
    Medicine (Baltimore); 2021 Oct; 100(40):e27459. PubMed ID: 34622870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.
    Zawitkowska J; Odój T; Drabko K; Zaucha-Prażmo A; Rudnicka J; Romiszewski M; Matysiak M; Kwiecińska K; Ćwiklińska M; Balwierz W; Owoc-Lempach J; Derwich K; Wachowiak J; Niedźwiecki M; Adamkiewicz-Drożyńska E; Trelińska J; Młynarski W; Kołtan A; Wysocki M; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Ociepa T; Urasiński T; Mizia-Malarz A; Sobol-Milejska G; Karolczyk G; Kowalczyk J
    Pediatr Hematol Oncol; 2017 May; 34(4):199-205. PubMed ID: 29040012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: A case report and retrospective review of Children's Oncology Group acute myeloid leukemia trials.
    Murphy BR; Roth M; Kolb EA; Alonzo T; Gerbing R; Wells RJ
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27700. PubMed ID: 30908863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of neuropsychological late effects in survivors of childhood leukemia.
    Kalafatçılar Aİ; Tüfekçi Ö; Ören H; Hız S; Güleryüz H; Akay A; Orçim E; Olgun Y; İrken G
    Pediatr Hematol Oncol; 2014 Mar; 31(2):181-93. PubMed ID: 24088177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verbal cognitive functioning and learning in girls treated for acute lymphoblastic leukemia by chemotherapy with or without cranial irradiation.
    Précourt S; Robaey P; Lamothe I; Lassonde M; Sauerwein HC; Moghrabi A
    Dev Neuropsychol; 2002; 21(2):173-95. PubMed ID: 12139198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.
    Dördelmann M; Schrappe M; Reiter A; Zimmermann M; Graf N; Schott G; Lampert F; Harbott J; Niemeyer C; Ritter J; Dörffel W; Nessler G; Kühl J; Riehm H
    Leukemia; 1998 May; 12(5):645-51. PubMed ID: 9593260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.
    Meyr F; Escherich G; Mann G; Klingebiel T; Kulozik A; Rossig C; Schrappe M; Henze G; von Stackelberg A; Hitzler J
    Br J Haematol; 2013 Jul; 162(1):98-106. PubMed ID: 23594030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].
    Steinberg S; Hartmann R; Wisniewski S; Berger K; Beck JD; Henze G
    Klin Padiatr; 1998; 210(4):200-6. PubMed ID: 9743953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The childhood leukemias.
    Colby-Graham MF; Chordas C
    J Pediatr Nurs; 2003 Apr; 18(2):87-95. PubMed ID: 12720205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
    Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
    Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
    Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological functioning of children treated for acute lymphoblastic leukemia: impact of whole brain radiation therapy.
    Annett RD; Hile S; Bedrick E; Kunin-Batson AS; Krull KR; Embry L; MacLean WE; Noll RB
    Psychooncology; 2015 Feb; 24(2):181-9. PubMed ID: 24890730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down syndrome and acute lymphoblastic leukaemia.
    Whitlock JA
    Br J Haematol; 2006 Dec; 135(5):595-602. PubMed ID: 17054672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. More good news about neuropsychological late effects in long-term survivors of acute lymphoblastic leukemia.
    Waber DP
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):86-7. PubMed ID: 11990710
    [No Abstract]   [Full Text] [Related]  

  • 36. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
    Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
    Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
    J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periconceptional vitamin useand leukemia risk in children with Down syndrome: a Children's Oncology Group study.
    Ross JA; Blair CK; Olshan AF; Robison LL; Smith FO; Heerema NA; Roesler M
    Cancer; 2005 Jul; 104(2):405-10. PubMed ID: 15952191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients.
    Quarello P; Berger M; Rivetti E; Galletto C; Masetti R; Manicone R; Barisone E; Pession A; Fagioli F
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):208-16. PubMed ID: 22395219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity.
    Buizer AI; de Sonneville LM; van den Heuvel-Eibrink MM; Veerman AJ
    Pediatr Blood Cancer; 2005 Sep; 45(3):281-90. PubMed ID: 15806539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.